U.S. flag

An official website of the United States government

NIH: Fogarty International Center NIH: Fogarty International Center
Advancing Science for Global Health
Advancing Science for Global Health
Home > Grants > Search Current & Recent Grants > Treatment response and microRNA profiles in triple negative breast cancer patients receiving standard chemotherapy (TARMAC) Print

COVID-19: COVID-19 public health information from the US CDC | COVID-19 research information from the US NIH | Español | COVID-19 resources for global health researchers

Treatment response and microRNA profiles in triple negative breast cancer patients receiving standard chemotherapy (TARMAC)

The following grant was awarded by, is supported by, is administered by or is in partnership with the Fogarty International Center at the U.S. National Institutes of Health (NIH).

Funding Fogarty Program

Emerging Global Leader

Project Information in NIH RePORTER

Treatment response and microRNA profiles in triple negative breast cancer patients receiving standard chemotherapy (TARMAC)

Principal Institution

University of Ibadan College of Medicine

Principal Investigator(s) (PI)

Ntekim, Atara Isaiah

Project Contact Information

Email: kimata2000@hotmail.com

Year(s) Awarded

2018-2023

Collaborating Country

Nigeria

Collaborators

University of Chicago

Related World Regions / Countries

Related Global Health Research Topics